Different profiles of body mass index variation among patients with multidrug-resistant tuberculosis: a retrospective cohort study
Open Access
- 28 April 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Infectious Diseases
- Vol. 20 (1), 1-10
- https://doi.org/10.1186/s12879-020-05028-0
Abstract
BackgroundDespite the predictive role of body weight variation in treatment outcome in multidrug-resistant tuberculosis (MDR-TB), few corroborating data are available. We studied weight variation in patients with MDR-TB to identify groups of weight change and to determine factors that influence these changes.MethodsWe analyzed patients with rifampicin resistance who were treated with an MDR-TB treatment regimen between June 07, 2016 and June 22, 2018 at three major drug-resistant TB centers in Guinea. Patients were seen monthly until the end of treatment. Clinical outcome was the body mass index (BMI). We used a linear mixed model to analyze trajectories of BMI and a latent class mixed model to identify groups of BMI trajectories.ResultsOf 232 patients treated for MDR-TB during the study period, 165 were analyzed. These patients had a total of 1387 visits, with a median of 5 visits (interquartile range, 3-8 visits). Monthly BMI increase was 0.24 (SE 0.02) per kg/m(2). Factors associated with faster BMI progression were success of MDR-TB treatment (0.24 [SE 0.09] per kg/m(2); p=0.0205) and absence of lung cavities on X-ray (0.18 [0.06] per kg/m(2); p=0.0068). Two groups of BMI change were identified: rapid BMI increase (n=121; 85%) and slow BMI increase (n=22; 15%). Patients in the slow BMI increase group were mostly female (68%) had no history of TB treatment (41%), had a positive HIV infection (59%), and had a more severe clinical condition at baseline, characterized by a higher frequency of symptoms including depression (18%), dyspnea (68%), poor adherence to MDR-TB treatment (64%), lower platelet count, and higher SGOT. These patients also had a longer time to initial culture conversion (log-rank test: p=0.0218).ConclusionQuantitative BMI data on patients with MDR-TB treated with a short regimen allowed the identification of subgroups of patients with different trajectories of BMI and emphasized the usefulness of BMI as a biomarker for the monitoring of MDR-TB treatment outcome.Other Versions
This publication has 16 references indexed in Scilit:
- Association between Body Mass Index and Sputum Culture Conversion among South Korean Patients with Multidrug Resistant Tuberculosis in a Tuberculosis Referral HospitalInfection & Chemotherapy, 2016
- Dynamical Biostatistical ModelsPublished by Taylor & Francis Ltd ,2015
- Weight variation over time and its relevance among multidrug-resistant tuberculosis patientsInternational Journal of Infectious Diseases, 2014
- Body mass index predictive of sputum culture conversion among MDR-TB patients in IndonesiaThe International Journal of Tuberculosis and Lung Disease, 2014
- Weight Gain and Response to Treatment for Multidrug-Resistant TuberculosisThe American Journal of Tropical Medicine and Hygiene, 2013
- Impact of malnutrition on clinical presentation, clinical course, and mortality in MDR-TB patientsEpidemiology and Infection, 2010
- Adherence: Comparison of Methods to Assess Medication Adherence and Classify NonadherenceAnnals of Pharmacotherapy, 2009
- Parametric latent class joint model for a longitudinal biomarker and recurrent eventsStatistics in Medicine, 2007
- Malnutrition and Pulmonary TuberculosisClinical Infectious Diseases, 2002
- Synergism of nutrition, infection, and immunity: an overviewThe American Journal of Clinical Nutrition, 1997